Viscosupplementation for Osteoarthritis of the Knee: Strategies to Improve Patient Outcomes CME

Andrew I. Spitzer, MD; William Arnold, MD Author Information and Disclosures

Release Date: October 13, 2008; Valid for credit through October 13, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

The content of this CME activity, "Viscosupplementation for Osteoarthritis of the Knee: Strategies to Improve Patient Outcomes," was developed as a presentation for release on Medscape.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Postgraduate Institute for Medicine. All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means -- electronic or mechanical -- without first obtaining written permission from Postgraduate Institute for Medicine and XME.
Genzyme Biosurgery
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. List the pathophysiologic factors involved in osteoarthritis (OA) of the knee, with particular focus on the older, functionally active patient population.
  2. Review available nonsurgical treatment options for OA of the knee.
  3. Identify placement of viscosupplementation on a treatment algorithm for OA of the knee.
Authors and Disclosures

Andrew I. Spitzer, MD
Disclosure: Consulting fees; fees for non-CME services received directly from a commercial interest of their agents; contracted research: Genzyme Biosurgery


William Arnold, MD
Disclosure: Consultant: Genzyme Biosurgery
 
Postgraduate Institute for Medicine
This educational activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Excellence in Medical Education (XME). PIM is accredited by the ACCME to provide continuing medical education (CME) for physicians.

Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.